ConductScience.org, home

Paper9561389

Single-dose cefodizime as infection prophylaxis in abdominal surgery: a prospective multicenter study.

Thalhammer F and 9 others. Infection, 1998. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Single-dose cefodizime as infection prophylaxis in abdominal surgery: a prospective multicenter study. Papers, record 9561389. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9561389

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Single-dose cefodizime as infection prophylaxis in abdominal surgery: a prospective multicenter study.
PubMed
Journal
Infection
PubMed
Year
1998
PubMed
Publication types
Journal Article, Multicenter Study
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0
iCite
Revised in PubMed
2019-08-31
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Thalhammer FF
2Traunmüller FF
3Böhming HJH J
4Depisch DD
5Ilias WW
6Hollenstein UU
7Salem GG
8Wayand WW
9Burgmann HH
10Breyer SS

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AbdomenMajor topic
Bacterial InfectionsMajor topic
CefotaximeMajor topic
CephalosporinsMajor topic
Postoperative ComplicationsMajor topic
Adult
Aged
Female
Humans
Male
Middle Aged
Pilot Projects
Prospective Studies

Source PubMed

Download CSV of topics

References7

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18875279Immunomodulating effects of antibiotics: literature review.Infection1996https://conductscience.org/library/papers/8875279PubMed
22105115Single dose cefotaxime plus metronidazole versus three dose cefuroxime plus metronidazole as prophylaxis against wound infection in colorectal surgery: multicentre prospective randomised study.BMJ1990https://conductscience.org/library/papers/2105115PubMed
33450392Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration.Clin Ther1987https://conductscience.org/library/papers/3450392PubMed
41791080Prophylaxis of postoperative infections.Infection1991https://conductscience.org/library/papers/1791080PubMed
53287963Antibiotics in surgery. An overview.Am J Surg1988https://conductscience.org/library/papers/3287963PubMed
69210690Prospective randomized comparison of cefodizime versus cefuroxime for perioperative prophylaxis in patients undergoing coronary artery bypass grafting.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/9210690PubMed
71280568Cefodizime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.Drugs1992https://conductscience.org/library/papers/1280568PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9561389

GET https://conductscience.org/api/papers/v1/9561389/authors